{"id":"https://openalex.org/W2072232675","doi":"https://doi.org/10.2133/dmpk.17.199","title":"Metabolism of Selegiline Hydrochloride, a Selective Monoamine B-type Inhibitor, in Human Liver Microsomes","display_name":"Metabolism of Selegiline Hydrochloride, a Selective Monoamine B-type Inhibitor, in Human Liver Microsomes","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2072232675","doi":"https://doi.org/10.2133/dmpk.17.199","mag":"2072232675","pmid":"https://pubmed.ncbi.nlm.nih.gov/15618670"},"language":"en","primary_location":{"id":"doi:10.2133/dmpk.17.199","doi":"https://doi.org/10.2133/dmpk.17.199","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.17.199","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113953230","display_name":"Takahiro Kamada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]},{"id":"https://openalex.org/I4210147619","display_name":"Fujimoto Pharmaceutical Corporation (Japan)","ror":"https://ror.org/042c70y92","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210147619"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takahiro Kamada","raw_affiliation_strings":["Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Osaka, Japan","Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan","Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Nishiotsuka, Matsubara-shi, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Osaka, Japan","institution_ids":["https://openalex.org/I4210147619"]},{"raw_affiliation_string":"Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan","institution_ids":["https://openalex.org/I317356780"]},{"raw_affiliation_string":"Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Nishiotsuka, Matsubara-shi, Osaka, Japan","institution_ids":["https://openalex.org/I4210147619"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toshio Chow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Chow","raw_affiliation_strings":["Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019251495","display_name":"Toyoko Hiroi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toyoko Hiroi","raw_affiliation_strings":["Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045181951","display_name":"Susumu Imaoka","orcid":"https://orcid.org/0000-0003-4350-2337","observed_orcids":["https://orcid.org/0000-0003-4350-2337"]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Susumu Imaoka","raw_affiliation_strings":["Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kazuhiko Morimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147619","display_name":"Fujimoto Pharmaceutical Corporation (Japan)","ror":"https://ror.org/042c70y92","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210147619"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiko Morimoto","raw_affiliation_strings":["Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Nishiotsuka, Matsubara-shi, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Nishiotsuka, Matsubara-shi, Osaka, Japan","institution_ids":["https://openalex.org/I4210147619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110119943","display_name":"Hironori Ohde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147619","display_name":"Fujimoto Pharmaceutical Corporation (Japan)","ror":"https://ror.org/042c70y92","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210147619"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hironori Ohde","raw_affiliation_strings":["Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Nishiotsuka, Matsubara-shi, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Research and Development, Fujimoto Pharmaceutical Corporation, Nishiotsuka, Matsubara-shi, Osaka, Japan","institution_ids":["https://openalex.org/I4210147619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113820659","display_name":"Yoshihiko Funae","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshihiko Funae","raw_affiliation_strings":["Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Osaka, Japan","institution_ids":["https://openalex.org/I317356780"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113820659"],"corresponding_institution_ids":["https://openalex.org/I317356780"],"apc_list":{"value":3580,"currency":"USD","value_usd":3580},"apc_paid":null,"fwci":0.1771,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.49408414,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"17","issue":"3","first_page":"199","last_page":"206"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11747","display_name":"Metal-Catalyzed Oxygenation Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selegiline","display_name":"selegiline","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cyp2b6","display_name":"CYP2B6","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cyp1a2","display_name":"CYP1A2","score":0.746999979019165},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":1.0},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9480000138282776},{"id":"https://openalex.org/keywords/n-demethylation","display_name":"N-demethylation","score":1.0},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.46700000762939453},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7870000004768372},{"id":"https://openalex.org/keywords/liver-microsomes","display_name":"liver microsomes","score":0.7839999794960022},{"id":"https://openalex.org/keywords/immunoinhibition","display_name":"immunoinhibition","score":0.7120000123977661},{"id":"https://openalex.org/keywords/mao-b-inhibitors","display_name":"monoamine oxidase B inhibitors","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C2776134090","wikidata":"https://www.wikidata.org/wiki/Q47495783","display_name":"Selegiline","level":4,"score":0.8362187743186951},{"id":"https://openalex.org/C50605568","wikidata":"https://www.wikidata.org/wiki/Q14912267","display_name":"CYP2B6","level":5,"score":0.8302731513977051},{"id":"https://openalex.org/C86745063","wikidata":"https://www.wikidata.org/wiki/Q3737406","display_name":"CYP1A2","level":4,"score":0.7861943244934082},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.7668397426605225},{"id":"https://openalex.org/C196013638","wikidata":"https://www.wikidata.org/wiki/Q14874295","display_name":"CYP2A6","level":5,"score":0.7548668384552002},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.6940309405326843},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6574533581733704},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6129535436630249},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.4348451495170593},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.41794806718826294},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.4100732207298279},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.37774622440338135},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2314196228981018},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2221274971961975},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17238128185272217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1172914206981659},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.2133/dmpk.17.199","doi":"https://doi.org/10.2133/dmpk.17.199","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.17.199","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:15618670","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15618670","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and pharmacokinetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W621109277","https://openalex.org/W1765706822","https://openalex.org/W1833106351","https://openalex.org/W1851833367","https://openalex.org/W1924401367","https://openalex.org/W1971796402","https://openalex.org/W1987655773","https://openalex.org/W1999326187","https://openalex.org/W2001351457","https://openalex.org/W2028603080","https://openalex.org/W2045356184","https://openalex.org/W2050548785","https://openalex.org/W2062178042","https://openalex.org/W2064498106","https://openalex.org/W2076064700","https://openalex.org/W2083081513","https://openalex.org/W2084119416","https://openalex.org/W2094017770","https://openalex.org/W2115717824","https://openalex.org/W2131528170","https://openalex.org/W2131614625","https://openalex.org/W2154535037","https://openalex.org/W2410779580","https://openalex.org/W2525355740","https://openalex.org/W2606572887","https://openalex.org/W6637904717","https://openalex.org/W6638630171","https://openalex.org/W6639034273","https://openalex.org/W6640217433","https://openalex.org/W6677362438","https://openalex.org/W6679474742","https://openalex.org/W6682422263","https://openalex.org/W6714256715"],"related_works":["https://openalex.org/W2082551494","https://openalex.org/W2050548785","https://openalex.org/W2154535037","https://openalex.org/W2135041507","https://openalex.org/W2141567033","https://openalex.org/W2045356184","https://openalex.org/W2061661903","https://openalex.org/W2067945842","https://openalex.org/W1997821165","https://openalex.org/W1894417684"],"abstract_inverted_index":{"The":[0],"participation":[1],"of":[2,10,36,46,57,73,159,164,171],"cytochrome":[3],"P-450":[4],"(CYP)":[5],"isoforms":[6,18],"in":[7,20,156,174],"the":[8,28,34,44,117,144,157,162,169],"metabolism":[9,35,45,158],"selegiline":[11,47,74,87,100,160],"was":[12,90,103],"investigated.":[13],"Experiments":[14],"using":[15,82],"recombinant":[16],"CYP":[17,30],"expressed":[19],"human":[21,84,111,175],"lymphoblastoid":[22],"cells":[23],"showed":[24],"CYP2B6":[25,59,149,154],"to":[26,43,143],"be":[27,141],"major":[29],"isoform":[31],"involved":[32],"with":[33,148,168],"selegiline.":[37],"CYP1A2":[38],"and":[39,69,77,96,130,150],"CYP3A4":[40,76],"also":[41],"contributed":[42],"but":[48,161],"their":[49],"catalytic":[50],"activities":[51],"were":[52],"much":[53],"less":[54],"than":[55,75],"that":[56,138],"CYP2B6.":[58],"had":[60,116],"a":[61],"higher":[62],"affinity":[63],"for":[64],"both":[65,122],"N-depropagylation":[66,88],"(K(m)=21.4":[67],"microM)":[68,72],"N-demethylation":[70,101,128],"(K(m)=25.2":[71],"CYP1A2.":[78],"In":[79,109,152],"immunoinhibition":[80],"studies":[81],"mixed":[83],"hepatic":[85,112],"microsomes,":[86,113],"activity":[89,102,129],"most":[91,104],"strongly":[92],"inhibited":[93,105,125],"by":[94,106],"anti-CYP2B":[95,107,114],"anti-CYP3A":[97],"antibodies,":[98],"while":[99],"antibody.":[108],"CYP2B6-rich":[110],"antibody":[115],"strongest":[118],"inhibitory":[119],"effects":[120],"on":[121],"activities.":[123],"Selegiline":[124],"CYP2B6-mediated":[126],"(S)-mephenytoin":[127,132],"CYP2C19-mediated":[131],"4'-hydroxylation":[133],"activity.":[134],"These":[135],"findings":[136],"suggest":[137],"attention":[139],"should":[140],"paid":[142],"drug-drug":[145],"interaction":[146],"associated":[147],"CYP2C19.":[151],"conclusion,":[153],"participates":[155],"degree":[163],"its":[165,172],"contribution":[166],"varies":[167],"level":[170],"expression":[173],"liver.":[176]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}